Enterovirus Causing Progression of Heart Failure in a Patient with a History of Myocardial Infarction

Agnieszka Pawlak1, Maciej Przybylski, Malgorzata Frontczak-Baniewicz

  • 1Department of Invasive Cardiology, Central Clinical Hospital of the Ministry of Interior, Warsaw, Poland.

Insights

Human enteroviruses (HEV) can cause heart failure (HF) after myocardial infarction (MI). This study suggests HEV may worsen HF progression, and treatment with interferon- improved a patient's condition.

Area of Science:

  • Cardiology
  • Virology
  • Molecular Biology

Background:

  • Human enteroviruses (HEV) are linked to myocarditis and dilated cardiomyopathy (DCM).
  • HEV presence in myocardium is documented in various heart conditions.
  • The role of HEV in heart failure (HF) post-myocardial infarction (MI) is largely unexplored.

Observation:

  • A case study of a 54-year-old female patient with a history of MI and progressive HF.
  • Investigations were conducted to identify potential causes for HF progression.

Findings:

  • The study identified HEV as a potential etiological factor contributing to HF progression in the patient.
  • The presence of the HEV genome in the myocardium was investigated in the context of HF post-MI.

Implications:

  • This suggests HEV could be a significant factor in HF development and progression after MI.
  • Interferon- treatment showed clinical improvement, supporting the hypothesis of HEV involvement.
  • Further research into HEV's role in post-MI cardiac dysfunction is warranted.

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
246
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
383
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
603
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
125
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.6K
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.1K